Utkarsh Bank Targets 3–3.5% Credit Cost, JLG ~25%

Utkarsh Small Finance Bank Limited — Q1 FY27 Earnings Call (held Aug 03, 2026)

1. Overall Tone of Management: Optimistic

• Management repeatedly signals “measurable improvements” and that the bank is “moving in the right direction.”
• They frame FY27 as “a year of rebuilding earnings strength” and explicitly guide to improving profitability trajectory (“recovery process is firmly underway”).
• Even while acknowledging losses (“net loss of INR34 crores”), they emphasize the loss reduction (“more than 80%”) and improving KPIs (GNPA, slippages, collections, funding cost).

2. Key Themes from Management Commentary

• Credit cycle stabilization & improving asset quality
• JLG collections remain very strong: “X-bucket collection efficiency… 99.7%”.
• SMA pools contracted; fresh slippages reduced sharply.
• GNPA improved to “5.9% as of June 2026” (YoY and QoQ improvement cited).
• Diversification away from legacy-heavy JLG
• JLG share reduced structurally: “JLG portfolio now represents 26% of gross loan book” (vs 88% in Mar 2020).
• Secured lending increased to “51% of gross loan book”.
• Growth strategy = calibrated, quality-first
• Disbursements up strongly: “total disbursements grew by 49% YoY”; non-JLG disbursements up “93% YoY”.
• Management stresses: “grow assets of the right quality… rather than pursuing growth for its own sake.”
• CGFMU credit guarantee as a risk mitigant for incremental flows
• Coverage expanded: “~60%… up to Q4 FY26” and “around 80% upon including Q1 FY27 disbursements.”
• Credit cost benefit quantified: “mitigation of around INR75 crores… credit cost to 2.3%.”
• Liability franchise improvement supporting funding cost
• CASA + retail term deposits ratio improved to “83%” (from 74% a year ago).
• Cost of funds down to “7.7%” (YoY and QoQ declines cited), with expectation of further repricing benefit.
• Operational/technology transformation to scale with control
• Collections infrastructure: call center, training, >1,200 collection workforce.
• “Utkarsh 2.0” for automation, digital underwriting, monitoring; “about to launch new CBS.”
• Capital & balance sheet cleanup
• Plan to raise “around INR500 crores through NCDs” (Tier 2).
• ARC sale of stressed JLG/wheels portfolio to accelerate cleanup.
• Reverse merger expected to complete “in the next few months” (subject to NCLT).

3. Q&A Analysis

Theme A: Microfinance (JLG/MBBL) mix, growth, and whether JLG is being run down

• Core questions
• Expected JLG % of portfolio going forward; whether JLG will be run down.
• Total portfolio growth and JLG growth split.
• Management response
• JLG expected to stay around “~25%” over next 2–3 years.
• JLG growth “below 20%”; overall JLG+MBBL growth “15% to 20%”, while total bank growth “25% to 30%.”
• They argue “legacy pain can be called as past” due to guardrails + CGFMU coverage.
• Notable/partial
• They do not provide a detailed “run-down vs stabilize” plan beyond % targets; relies on qualitative confidence in guardrails + guarantee.

Theme B: Asset quality trajectory—NPA, credit cost, recoveries/upgradations

• Core questions
• Guidance for NPA/credit cost for rest of year; expected provisions.
• Why recoveries/upgradations were slower than expected; whether NPAs are non-recoverable.
• Segment-wise GNPA disclosure (MSME asked explicitly).
• Management response
• Credit cost guided conservatively: “3% to 3.5%” (upper-side).
• Recovery timing explanation: retail secured recoveries delayed due to “legal litigation bucket” and SARFAESI timelines.
• Expect recovery pickup: “Quarter 2 and quarter 3” pickup; Q1 “normally slow.”
• MSME GNPA provided: “INR169 crores (~3.8%).”
• Notable/partial
• They attribute slower recoveries to process/legal timing (plausible), but do not quantify how much of the litigation bucket is expected to resolve vs remain prolonged.

Theme C: MBBL underwriting quality and whether growth is from existing vs new-to-bank

• Core questions
• MBBL disbursement jump: existing customers only or new-to-bank?
• Underwriting differences vs JLG.
• Early stress / PAR / NPA “numbers.”
• Management response
• “99.9%… existing customers only”; new-to-bank only “piloted… 100 or 200.”
• Underwriting: dedicated underwriting team; separate credit assessment; CGFMU coverage.
• Early stress: post-April 2025 gross NPAs “below 2%… 1.85% to 1.9%”; CGFMU coverage “80%” including Q1 FY27 disbursements.
• Strong answer
• Provides specific customer-source split and post-guardrail NPA range.

Theme D: Recoveries headcount reallocation and whether recoveries will improve

• Core questions
• Whether recoveries will pick up; whether collection headcount will shift from normalization to write-offs/NPA recovery.
• Management response
• JLG collection efficiency >99.5% for 5–6 months; headcount ~1,100 for JLG collections.
• As credit cost normalizes, they will “shift some of this head count for recovery of the past NPAs and write-offs,” expecting traction in coming quarters.
• Notable
• This is a clear operational lever, but still lacks quantified recovery targets.

Theme E: Capital raising plans and CRAR impact

• Core questions
• Additional fundraises beyond INR500cr; equity vs Tier-2; CRAR uplift.
• Management response
• Raise “INR500 crores” via Tier-2 NCDs; repay INR195cr tranche early.
• Expected CRAR uplift: “~250 basis points.”
• “No capital equity raise… till end of FY27” (qualitative conditional on profitability trajectory).
• Strong/clear
• Provides mechanics (early redemption + Tier-2 classification) and CRAR uplift estimate.

Theme F: CGFMU mechanics, coverage, risk weight, and provisioning

• Core questions
• How much of MFI NPAs are covered; provisions held vs covered/uncovered.
• Whether CGFMU allows lower risk weights; risk weight on incremental book.
• Management response
• Coverage: for JLG+MBBL, “~INR170 crores gross NPA covered.”
• Provisioning: lifetime provisioning required INR46cr; “~INR29 crores already provided,” remaining ~INR17cr to come quarterly as bucket movement.
• Risk weight: benefit includes “zero risk weightage” but capped (15% crystallized portfolio cap; otherwise capped eligibility).
• Incremental risk weight example: out of INR100 incremental, INR15 gets zero risk weight; remaining INR85 still has risk weight.
• Notable
• They provide fairly granular CGFMU accounting/provisioning split and caps.

Theme G: Operating profit / cost-to-income and ROE path

• Core questions
• Why operating profit growth is slow; whether cost-to-income will stay controlled while growing 25–30%.
• FY27 ROA/credit cost guidance.
• Management response
• Operating profit improvement explained by disbursement trajectory and normalization of credit cost; other income stabilizing with processing fees.
• Cost-to-income: elevated due to income denominator contraction; expects improvement exiting FY27.
• ROE path: FY28 ROE “~15%”; “path to profitability through FY27,” with “2-digit upwards ROE by exit of FY27.”
• Notable
• They avoid giving explicit FY27 ROA/credit cost beyond credit cost range; relies on trajectory narrative.

4. Guidance / Outlook

Explicit guidance (quantitative)

• Loan book growth: “25% to 30%” (aiming for FY27; also similar growth expected next year in Q&A).
• Secured lending mix: “~55% of the portfolio” (target).
• NIM: “around 8%” (target).
• ROE: “~15% by FY28.”
• Credit cost (rest of year): “3% to 3.5%” (conservative upper-side).
• Provisioning / CGFMU-related: remaining CGFMU lifetime provisioning “~INR17 crores” to come as bucket movement (from Q&A).
• Cost of funds: Q1 FY27 cost of funds “7.7%”; expectation of further support from repricing.
• Capital raise: “around INR500 crores” via NCDs (Tier 2); expected CRAR uplift “~250 bps.”
• Liquidity/capital buffers (as of June 2026): LCR “216%”, capital adequacy “17.4%”.

Implicit signals (qualitative)

• FY27 framed as “rebuilding earnings strength” and “consolidation year.”
• Management expects pickup in recoveries in Q2/Q3 and normalized credit cost.
• They emphasize no growth for growth’s sake, and continued disciplined underwriting.
• They suggest operational scaling will come from productivity rather than branch expansion.

5. Standout Statements (direct quotes where useful)

• “FY27… a year of rebuilding earnings strength and translating operational improvements into sustainable financial outcomes.”
• “Total disbursements grew by 49% year-on-year… non-JLG… 93% YoY.”
• “X-bucket collection efficiency… 99.7%… up from 98.6% in quarter 1 of FY26.”
• “Fresh NPA slippages… reduced… to ~INR125 crores… compared with ~INR170 crores… and ~INR400 crores…”
• “JLG portfolio now represents 26% of the gross loan book…”
• “We expect the full impact of repricing actions to unfold progressively… providing further support to margin stability.”
• “We are aiming for a loan book growth of 25% to 30%… maintaining NIM of around 8% and delivering a ROE of ~15% by FY28.”
• “Credit cost… 3% to 3.5% as we go along.”
• “~60%… covered… increasing to around 80% upon including quarter 1 FY27 disbursements.”
• “This INR500 crores should inch up the CRAR by around 250 basis points.”
• “Worst is behind us… next few quarters are going to be really good quarters.”

6. Red Flags / Positive Signals

Positive signals
– Strong KPI improvements: collections (99.7%), SMA contraction, slippages down materially, GNPA improved.
– Clear diversification metrics (JLG down to 26%; secured up to 51%).
– CGFMU coverage expansion quantified to ~80% of incremental flows.
– Specific underwriting/customer-source clarity for MBBL (99.9% existing customers).
– Capital plan mechanics and CRAR uplift quantified.

Red flags / watch-outs
– Recoveries/upgradations slower than expected; explanation leans on “legal litigation bucket” without quantified resolution probability.
– Net loss persists (INR34 crores) despite “normalization” narrative—suggests profitability still fragile.
– Guidance is partly conditional (“market is also that way,” “trajectory,” “endeavor,” “conservative” credit cost), with limited hard targets for FY27 P&L.
– Some answers defer detail (e.g., segment GNPA requested and provided, but not all segment-level metrics are consistently disclosed upfront).

7. Historical Comparison & Consistency Analysis

a. Change in Tone Over Time

• Q2 FY26 (Nov 2025): “cautious optimism,” focus on stability; JLG headwinds; expectation that stress improves from Q3/Q4.
• Q3 FY26 (Feb 2026): “recalibration, resilience and cautious optimism”; still heavy legacy stress; net loss large (INR375cr).
• Q4 FY26 (May 2026): tone shifts to “renewed growth, proof of resilience and cautious optimism”; “green shoots” and improved GNPA/slippages; still net loss (INR188cr) but framed as transformation year.
• Q1 FY27 (Aug 2026): more confident “measurable improvements” and “recovery process firmly underway,” with explicit growth and ROE path.

Classification vs prior calls: More Optimistic
– Language becomes more outcome-oriented (“measurable improvements,” “tangible outcomes,” “recovery process firmly underway”) and includes clearer quantitative targets (loan growth, NIM, ROE, credit cost range).

b. Tracking Past Commitments vs Outcomes (selected)

1. “Worst is behind us / recovery path”
2. Past (Nov 2025 / Feb 2026 / May 2026): repeated “stress peaked / recovery underway” narrative.
3. Now (Aug 2026): still net loss (INR34cr) but much smaller; GNPA and slippages improved.

4. Flag: ✅ Partially delivered (credit metrics improved; profitability not fully normalized yet).

5. CGFMU coverage ramp

6. May 2026: ~45% covered (till Q3 FY26), ~70% including Q4 FY26.
7. Aug 2026: “~60%… up to Q4 FY26” and “around 80% upon including Q1 FY27.”

8. Flag: ✅ Delivered / on track (coverage progression continues).

9. Recoveries pickup expectation

10. Earlier calls: expectation of improving recoveries as collections normalize.
11. Now: management admits recoveries/upgradations were slower in Q1 and attributes to litigation bucket; expects pickup in Q2/Q3.

12. Flag: ⏳ Delayed (timing not fully met in Q1 FY27).

13. ROE path

14. Earlier: FY28 ROE ~15% repeatedly; FY27 path to profitability.
15. Now: “2-digit upwards ROE by exit of FY27.”
16. Flag: ⏳ Delayed/conditional (still net loss in Q1; exit FY27 ROE not yet demonstrated).

c. Narrative Shifts

• From “JLG stabilization” to “JLG share maintained but diversified growth engine”
• Earlier: JLG was the main stress focus; now: JLG is still important but management emphasizes secured/diversified growth and structural balance sheet transformation.
• CGFMU narrative becomes more operational
• Earlier: CGFMU described as protection/coverage; now: quantified mitigation impact on P&L and credit cost (INR75cr mitigation; credit cost 2.3%).
• Recoveries explanation shifts from “collections improving” to “legal timeline / litigation bucket”
• This is a subtle but important shift: it suggests some stress is not purely behavioral/collection-driven.

d. Consistency & Credibility Signals

• Credibility: Medium-High
• Consistent strategy: diversification + collections + underwriting discipline + technology.
• Quantification improved over time (coverage %, slippages, credit cost, CRAR uplift).
• However, profitability normalization remains delayed (net loss persists), and some timing-dependent statements (recoveries pickup) still require validation in subsequent quarters.

e. Evolution of Key Themes

• Demand/disbursements: improving trajectory (Q1 FY27 disbursements +49% YoY; management expects H2 pickup).
• Margins/funding: cost of funds down; repricing benefit expected to continue.
• Asset quality: clear improvement trend (GNPA down, slippages down, SMA pools down).
• Risk mitigation: CGFMU coverage expansion becomes central to incremental risk framing.
• Operational efficiency: collections infrastructure + Utkarsh 2.0 increasingly emphasized as scalability enablers.

f. Additional Insights (cross-period intelligence)

• Management’s confidence is increasingly tied to two time-lag mechanisms:
  1) Guardrail/behavioral normalization (post-April 2025 book performance).
  2) Legal resolution timelines (SARFAESI litigation bucket delaying recoveries).
• This implies that even if “fresh stress” is controlled, P&L normalization may remain lumpy quarter-to-quarter due to recovery timing—consistent with net loss still present in Q1 FY27.